Health Care & Life Sciences » Pharmaceuticals | Zynerba Pharmaceuticals Inc.

Zynerba Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
943.90
810.00
278.90
7.30
-
86
Cost of Goods Sold (COGS) incl. D&A
-
-
-
-
94.20
-
Gross Income
-
-
-
-
94.20
-
SG&A Expense
1,529.00
5,950.70
12,784.00
23,139.60
32,728.80
40,384.30
EBIT
634.40
5,167.70
12,531.20
23,207.60
32,823.00
40,397.80
Unusual Expense
-
500.00
-
-
-
-
Non Operating Income/Expense
-
-
7.40
288.60
291.20
474.70
Interest Expense
2.40
1.80
-
-
-
-
Pretax Income
636.80
5,669.60
12,523.80
23,416.10
32,012.30
39,911.20
Income Tax
-
-
27.50
27.50
-
-
Consolidated Net Income
636.80
5,669.60
12,551.40
23,388.50
32,012.30
39,911.20
Net Income
636.80
5,669.60
12,551.40
23,388.50
32,012.30
39,911.20
Net Income After Extraordinaries
636.80
5,669.60
12,551.40
23,388.50
32,012.30
39,911.20
Net Income Available to Common
798.60
5,757.50
12,551.40
23,388.50
32,012.30
39,911.20
EPS (Basic)
0.09
0.63
2.82
2.58
2.48
2.61
Basic Shares Outstanding
9,184.00
9,184.00
4,457.70
9,070.20
12,914.80
15,308.90
EPS (Diluted)
0.09
0.63
2.82
2.58
2.48
2.61
Diluted Shares Outstanding
9,184.00
9,184.00
4,457.70
9,070.20
12,914.80
15,308.90
EBITDA
585.10
5,140.70
12,505.10
23,132.30
32,728.80
40,298.30
Non-Operating Interest Income
-
-
-
80.20
519.60
961.30
Preferred Dividends
161.80
88.00
-
-
-
-

About Zynerba Pharmaceuticals

View Profile
Address
80 West Lancaster Avenue
Devon Pennsylvania 19333
United States
Employees -
Website http://zynerba.com
Updated 07/08/2019
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It engages in the development and commercialization of transdermal pharmaceutically-produced cannabinoid treatments for rare and near-rare neurological and psychiatric, or neuropsychiatric, disorders in patients with high unmet medical needs. The company was founded by Audra L.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.